Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score

BACKGROUND: The 300IR (index of reactivity) 5-grass pollen tablet has favorable short-term and sustained clinical efficacy in patients with grass pollen-induced allergic rhinoconjunctivitis (ARC). Here, we report maintenance of efficacy and safety over 2 years following treatment discontinuation. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Didier, Alain, Malling, Hans-Jørgen, Worm, Margitta, Horak, Friedrich, Sussman, Gordon L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474569/
https://www.ncbi.nlm.nih.gov/pubmed/26097680
http://dx.doi.org/10.1186/s13601-015-0057-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474569/
https://www.ncbi.nlm.nih.gov/pubmed/26097680
http://dx.doi.org/10.1186/s13601-015-0057-8

Ejemplares similares